A nurse led lipid clinic

Journal of Community Nursing

Volumn 14, Issue 2, 2000, Pages

  Curry, Jean ^a  

^a Bondgate Surgery   (United Kingdom)

Author keywords

Coronary heart disease; Health promoting activities; Lipid levels

Indexed keywords

EID: 52849099685     PISSN: 02634465     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Bethel, J. N. (1989) 'Rehabilitation after Myocardial Infarction.' The Practitioner. 223: 335-339.
2. Campbell, N. C., Thain, J., Deans, H. G. (1993). Secondary Prevention Clinics for Coronary Heart Disease? Randomised Trial of Effect on Health. British Medical Journal. 316: 1434-7.
3. COMA Committee (1994). Medical Aspects of Food Policy: Dietary reference values for food and energy nutrients for the U.K. Report of the panel on dietary reference values RH 5546. HMSO, London.
4. Daly, L. E., Graham, I. M. 'Does stopping smoking delay onset of angina after infarction? British Medical Journal. 291: 935-937.
5. Lewin, B. (1992). 'Effects of Self Help post Myocardial Infarction Rehabilitation on Psychological Adjustment and use of Health Services.' Lancet. 339: 1036-1040.
6. Mcllhey, J. (1988). Answering Back: Public Views on food and health information. Horton Publishing Ltd, Bradford.
7. Pan, H. Y., De Vault, A. R., Swites, B. J. (1996). 'Pharmacokinetics and Pharmacodynamics of Pravastatin alone with Cholestryamine in Hypercholesteraemic Patients. A double-blind randomised parallel group comparison.' Clinical Drug Intervention. 12: 119-126.
8. Scandinavian Simvastatin Survival Study Group (1994). 'Randomised trial of Cholesterol Lowering in 4444 patients with Coronary Heart Disease.' Lancet. 334: 1383-9.
9. Scandinavian Simvastatin Survival Study Group (1995). 'Baseline Serum Cholesterol and Treatment Effect in the Scandinavian Survival Study (4s).' Lancet. 345: 1274-1275.
10. Schulte, K. L., Beils, S. (1996). 'Efficacy and tolerability of fluvastatin and simvastatin in hypereholesteraemic patients. A double-blind randomised parallel group comparison.' Clinical Drug Investigation 12: 119-126.